Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
14.93
-0.05 (-0.33%)
At close: Aug 13, 2025, 4:00 PM
14.67
-0.27 (-1.77%)
Pre-market: Aug 14, 2025, 9:13 AM EDT

Oscar Health Statistics

Total Valuation

Oscar Health has a market cap or net worth of $3.86 billion. The enterprise value is $1.61 billion.

Market Cap 3.86B
Enterprise Value 1.61B

Important Dates

The last earnings date was Wednesday, August 6, 2025, before market open.

Earnings Date Aug 6, 2025
Ex-Dividend Date n/a

Share Statistics

Oscar Health has 258.24 million shares outstanding. The number of shares has decreased by -4.81% in one year.

Current Share Class 222.73M
Shares Outstanding 258.24M
Shares Change (YoY) -4.81%
Shares Change (QoQ) -16.48%
Owned by Insiders (%) 3.39%
Owned by Institutions (%) 69.84%
Float 210.30M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.35
Forward PS 0.32
PB Ratio 3.33
P/TBV Ratio 3.33
P/FCF Ratio 3.21
P/OCF Ratio 3.12
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.15
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 1.34

Financial Position

The company has a current ratio of 0.89, with a Debt / Equity ratio of 0.31.

Current Ratio 0.89
Quick Ratio 0.84
Debt / Equity 0.31
Debt / EBITDA n/a
Debt / FCF 0.30
Interest Coverage -5.47

Financial Efficiency

Return on equity (ROE) is -13.96% and return on invested capital (ROIC) is -5.35%.

Return on Equity (ROE) -13.96%
Return on Assets (ROA) -1.42%
Return on Invested Capital (ROIC) -5.35%
Return on Capital Employed (ROCE) -8.53%
Revenue Per Employee $4.47M
Profits Per Employee -$67,180
Employee Count 2,400
Asset Turnover 1.88
Inventory Turnover n/a

Taxes

In the past 12 months, Oscar Health has paid $9.33 million in taxes.

Income Tax 9.33M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -16.96% in the last 52 weeks. The beta is 1.86, so Oscar Health's price volatility has been higher than the market average.

Beta (5Y) 1.86
52-Week Price Change -16.96%
50-Day Moving Average 15.82
200-Day Moving Average 15.03
Relative Strength Index (RSI) 49.47
Average Volume (20 Days) 30,865,689

Short Selling Information

The latest short interest is 60.08 million, so 23.27% of the outstanding shares have been sold short.

Short Interest 60.08M
Short Previous Month 28.59M
Short % of Shares Out 23.27%
Short % of Float 28.57%
Short Ratio (days to cover) 1.57

Income Statement

In the last 12 months, Oscar Health had revenue of $10.73 billion and -$161.23 million in losses. Loss per share was -$0.69.

Revenue 10.73B
Gross Profit 1.84B
Operating Income -129.47M
Pretax Income 23.89M
Net Income -161.23M
EBITDA -99.03M
EBIT -129.47M
Loss Per Share -$0.69
Full Income Statement

Balance Sheet

The company has $3.54 billion in cash and $357.22 million in debt, giving a net cash position of $2.24 billion or $8.68 per share.

Cash & Cash Equivalents 3.54B
Total Debt 357.22M
Net Cash 2.24B
Net Cash Per Share $8.68
Equity (Book Value) 1.16B
Book Value Per Share 4.49
Working Capital -552.34M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $1.23 billion and capital expenditures -$32.69 million, giving a free cash flow of $1.20 billion.

Operating Cash Flow 1.23B
Capital Expenditures -32.69M
Free Cash Flow 1.20B
FCF Per Share $4.65
Full Cash Flow Statement

Margins

Gross margin is 17.20%, with operating and profit margins of -1.21% and -1.50%.

Gross Margin 17.20%
Operating Margin -1.21%
Pretax Margin -1.41%
Profit Margin -1.50%
EBITDA Margin -0.92%
EBIT Margin -1.21%
FCF Margin 11.20%

Dividends & Yields

Oscar Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 4.81%
Shareholder Yield 4.81%
Earnings Yield -4.18%
FCF Yield 31.17%
Dividend Details

Analyst Forecast

The average price target for Oscar Health is $12.79, which is -14.33% lower than the current price. The consensus rating is "Sell".

Price Target $12.79
Price Target Difference -14.33%
Analyst Consensus Sell
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3